Clarke DF, Acosta EP, Cababasay M, Wang J, et al. Raltegravir (RAL) in neonates: Dosing, pharmacokinetics (PK), and safety in HIV-1 exposed neonates at risk of infection (IMPAACT P1110). J Acquir Immune Defic Syndr 2020 Jan 6. doi: 10.1097/QAI.0000000000002294.
PMID: 31913995